Mesterolone

Revision as of 19:58, 27 September 2011 by WikiBot (Talk | contribs)

Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mesterolone.svg
Mesterolone
Systematic (IUPAC) name
 ?
Identifiers
CAS number 1424-00-6
ATC code G03BB01
PubChem 15020
Chemical data
Formula C20H32O2 
Mol. mass 304.467 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

WikiDoc Resources for

Mesterolone

Articles

Most recent articles on Mesterolone

Most cited articles on Mesterolone

Review articles on Mesterolone

Articles on Mesterolone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mesterolone

Images of Mesterolone

Photos of Mesterolone

Podcasts & MP3s on Mesterolone

Videos on Mesterolone

Evidence Based Medicine

Cochrane Collaboration on Mesterolone

Bandolier on Mesterolone

TRIP on Mesterolone

Clinical Trials

Ongoing Trials on Mesterolone at Clinical Trials.gov

Trial results on Mesterolone

Clinical Trials on Mesterolone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mesterolone

NICE Guidance on Mesterolone

NHS PRODIGY Guidance

FDA on Mesterolone

CDC on Mesterolone

Books

Books on Mesterolone

News

Mesterolone in the news

Be alerted to news on Mesterolone

News trends on Mesterolone

Commentary

Blogs on Mesterolone

Definitions

Definitions of Mesterolone

Patient Resources / Community

Patient resources on Mesterolone

Discussion groups on Mesterolone

Patient Handouts on Mesterolone

Directions to Hospitals Treating Mesterolone

Risk calculators and risk factors for Mesterolone

Healthcare Provider Resources

Symptoms of Mesterolone

Causes & Risk Factors for Mesterolone

Diagnostic studies for Mesterolone

Treatment of Mesterolone

Continuing Medical Education (CME)

CME Programs on Mesterolone

International

Mesterolone en Espanol

Mesterolone en Francais

Business

Mesterolone in the Marketplace

Patents on Mesterolone

Experimental / Informatics

List of terms related to Mesterolone

Mesterolone is an orally applicable androgen, and DHT derivative. It is sold under the brand name Proviron, by Schering. In the late 70's and early 80's it was used with some success in controlled studies of men suffering from various forms of depression.

In one randomized, double-blind 4-week trial, 38 dysthymic men were administered 75mg daily. Itil & Colleagues reported an improvement of symptoms which included anxiety, lack of drive and desire. Next, they administered a high dose (450mg/day) or placebo in a 6-week randomized trial of 52 men with a mean age of 40 years, suffering from dysthymia, unipolar and bipolar depression. Both the mesterolone and placebo groups improved significantly and there were no statistically significant differences between the two groups. In this series of studies mesterolone lead to a significant decrease in LH and testosterone levels. This is probably as a result of the extremely high dose used. In another, 100mg mesterolone cipionate was administered twice monthly. With regards to plasma T levels, there was no difference between the treated vs untreated group, and baseline LH levels were minimally affected.[1]

Mesterolone is a relatively weak androgen and rarely used for replacement therapies.[2]


References

  1. Archives of Dermatological Research (1977), Testosterone levels and gonadotrophins in klinefelter's patients treated with injections of mesterolone cipionate
  2. Human Reproduction Update (2004), Testosterone replacement therapy: current trends and future directions
Cost Effectiveness of Mesterolone

| group5 = Clinical Trials Involving Mesterolone | list5 = Ongoing Trials on Mesterolone at Clinical Trials.govTrial results on MesteroloneClinical Trials on Mesterolone at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Mesterolone | list6 = US National Guidelines Clearinghouse on MesteroloneNICE Guidance on MesteroloneNHS PRODIGY GuidanceFDA on MesteroloneCDC on Mesterolone


| group7 = Textbook Information on Mesterolone | list7 = Books and Textbook Information on Mesterolone


| group8 = Pharmacology Resources on Mesterolone | list8 = AND (Dose)}} Dosing of MesteroloneAND (drug interactions)}} Drug interactions with MesteroloneAND (side effects)}} Side effects of MesteroloneAND (Allergy)}} Allergic reactions to MesteroloneAND (overdose)}} Overdose information on MesteroloneAND (carcinogenicity)}} Carcinogenicity information on MesteroloneAND (pregnancy)}} Mesterolone in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Mesterolone


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Mesterolone | list9 = AND (pharmacogenomics)}} Genetics of MesteroloneAND (pharmacogenomics)}} Pharmacogenomics of MesteroloneAND (proteomics)}} Proteomics of Mesterolone


| group10 = Newstories on Mesterolone | list10 = Mesterolone in the newsBe alerted to news on MesteroloneNews trends on Mesterolone</small>


| group11 = Commentary on Mesterolone | list11 = Blogs on Mesterolone

| group12 = Patient Resources on Mesterolone | list12 = Patient resources on MesteroloneDiscussion groups on MesterolonePatient Handouts on MesteroloneDirections to Hospitals Treating MesteroloneRisk calculators and risk factors for Mesterolone


| group13 = Healthcare Provider Resources on Mesterolone | list13 = Symptoms of MesteroloneCauses & Risk Factors for MesteroloneDiagnostic studies for MesteroloneTreatment of Mesterolone

| group14 = Continuing Medical Education (CME) Programs on Mesterolone | list14 = CME Programs on Mesterolone

| group15 = International Resources on Mesterolone | list15 = Mesterolone en EspanolMesterolone en Francais

| group16 = Business Resources on Mesterolone | list16 = Mesterolone in the MarketplacePatents on Mesterolone

| group17 = Informatics Resources on Mesterolone | list17 = List of terms related to Mesterolone


}}


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox